Compare AFBI & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AFBI | STIM |
|---|---|---|
| Founded | 1928 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.6M | 136.3M |
| IPO Year | N/A | 2018 |
| Metric | AFBI | STIM |
|---|---|---|
| Price | $20.02 | $1.35 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 6.9K | ★ 2.1M |
| Earning Date | 10-24-2025 | 11-04-2025 |
| Dividend Yield | ★ 7.49% | N/A |
| EPS Growth | ★ 37.47 | N/A |
| EPS | ★ 1.17 | N/A |
| Revenue | $31,784,000.00 | ★ $129,873,000.00 |
| Revenue This Year | N/A | $101.67 |
| Revenue Next Year | N/A | $10.87 |
| P/E Ratio | $17.14 | ★ N/A |
| Revenue Growth | 3.87 | ★ 78.61 |
| 52 Week Low | $17.00 | $1.00 |
| 52 Week High | $22.50 | $5.92 |
| Indicator | AFBI | STIM |
|---|---|---|
| Relative Strength Index (RSI) | 62.68 | 30.82 |
| Support Level | $18.61 | $1.28 |
| Resistance Level | $20.25 | $1.51 |
| Average True Range (ATR) | 0.20 | 0.18 |
| MACD | 0.14 | 0.02 |
| Stochastic Oscillator | 85.98 | 12.82 |
Affinity Bancshares Inc is a holding company of Affinity Bank, a federally chartered stock savings bank that offers a variety of deposit accounts, including checking accounts, savings accounts, and certificate of deposit accounts. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial real estate loans, commercial and industrial loans, residential real estate loans, construction and land loans, and consumer loans. It also invests in securities, which consist of mortgage-backed securities and obligations issued by United States government-sponsored enterprises and Federal Home Loan Bank stock.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.